pms-Ranitidine 150mg (2020-08-28)

Starting date:
August 28, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73873

Last updated:

Summary

  • Product: pms-Ranitidine 150mg

Reason

Presence of N-nitrosodimethylamine (NDMA) near the interim acceptable concentration limit in affected lot.

Depth of distribution

Wholesalers, Retailers, Healthcare establishments

Affected products

pms-Ranitidine 150mg

DIN, NPN, DIN-HIM

DIN 02242453

Dosage form

Tablet

Strength

Ranitidine Hydrochloride 150mg

Lot or serial number

619003

Companies

Recalling Firm
Pharmascience Inc.
611 ave Royalmount suite 100
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
611 ave Royalmount suite 100
Montreal
H4P 2T4
Quebec
CANADA